Pages that link to "Q30371274"
Jump to navigation
Jump to search
The following pages link to Targeting neurosteroid synthesis as a therapy for schizophrenia-related alterations induced by early psychosocial stress (Q30371274):
Displaying 9 items.
- The neurosteroidogenic enzyme 5α-reductase modulates the role of D1 dopamine receptors in rat sensorimotor gating (Q30367021) (← links)
- Finasteride inhibited brain dopaminergic system and open-field behaviors in adolescent male rats (Q47320877) (← links)
- The Neurosteroidogenic Enzyme 5α-Reductase Mediates Psychotic-Like Complications of Sleep Deprivation. (Q47773133) (← links)
- The 5α-Reductase Inhibitor Finasteride Exerts Neuroprotection Against Ischemic Brain Injury in Aged Male Rats. (Q52637945) (← links)
- Neurosteroids in Schizophrenia: Pathogenic and Therapeutic Implications. (Q52641631) (← links)
- Steroid 5α-reductase 2 deficiency leads to reduced dominance-related and impulse-control behaviors. (Q53433418) (← links)
- Androgen Regulation of the Mesocorticolimbic System and Executive Function. (Q55344917) (← links)
- Neurobehavioural complications of sleep deprivation: Shedding light on the emerging role of neuroactive steroids (Q90031876) (← links)
- The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia (Q93264329) (← links)